Boundless Bio (BOLD) Operating Expenses (2023 - 2026)
Boundless Bio (BOLD) posted quarterly Operating Expenses of $14.5 million for Q1 2026, down 16.53% year-over-year from $17.3 million in Q1 2025, and up 3.38% quarter-over-quarter from $14.0 million in Q4 2025.
Boundless Bio (BOLD) Operating Expenses (2023 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported Operating Expenses for 4 consecutive years, with $14.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses fell 16.53% year-over-year to $14.5 million; the TTM figure through Mar 2026 stood at $60.7 million (down 17.69% YoY), while the FY2025 annual figure was $63.6 million, down 13.26% from the prior year.
- Operating Expenses improved to $14.5 million in Q1 2026 per BOLD's latest filing, from $14.0 million in the prior quarter.
- Across five years, Operating Expenses topped out at $19.4 million in Q2 2024 and bottomed at $12.1 million in Q1 2023.
- Historically, Operating Expenses has averaged $15.9 million across 4 years, with a median of $15.1 million in 2025.
- Annual changes were most pronounced in 2024 — Operating Expenses jumped 39.68% — and 2025, when it declined 23.39%.
- Boundless Bio's Operating Expenses stood at $13.8 million in 2023, then jumped by 32.49% to $18.3 million in 2024, then retreated by 23.39% to $14.0 million in 2025, then gained by 3.38% to $14.5 million in 2026.
- Business Quant data shows BOLD's Operating Expenses at $14.5 million in Q1 2026, $14.0 million in Q4 2025, and $15.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 541.02 Mn |
| 10 | Boundless Bio | 67.01 Mn | 67.01 Mn | - | 24.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.38 Mn |
| Mar 31, 2026 | 14.48 Mn |
| Dec 31, 2025 | 14.00 Mn |
| Sep 30, 2025 | 15.15 Mn |
| Jun 30, 2025 | 17.06 Mn |
| Mar 31, 2025 | 17.34 Mn |
| Dec 31, 2024 | 18.28 Mn |
| Sep 30, 2024 | 18.72 Mn |
| Jun 30, 2024 | 19.39 Mn |
| Mar 31, 2024 | 16.88 Mn |
| Dec 31, 2023 | 13.80 Mn |
| Sep 30, 2023 | 14.95 Mn |
| Jun 30, 2023 | 13.96 Mn |
| Mar 31, 2023 | 12.09 Mn |